News for 'Clinical Science'

AIIMS chief warns against going for CT scan in mild COVID cases

AIIMS chief warns against going for CT scan in mild COVID cases

Rediff.com3 May 2021

"One CT scan is equivalent to 300 to 400 chest x-rays. According to data, repeated CT scans in younger age groups increase the risk of cancer in later life. Exposing yourself to radiation again and again may cause damage. So, there is no point in doing CT scan in mild COVID-19 if the oxygen saturation is normal," Guleria said.

23-yr-old becomes 1st COVID-19 case in Northeast

23-yr-old becomes 1st COVID-19 case in Northeast

Rediff.com24 Mar 2020

She had reached Delhi from London on March 18 and taken another flight to Kolkata, where she stayed for a few days with fever and a sore throat. From there she took a flight to Imphal via Agartala on March 21, official sources said.

Covaxin emergency use decision likely in 4-6 weeks: WHO

Covaxin emergency use decision likely in 4-6 weeks: WHO

Rediff.com10 Jul 2021

There is a process to be followed for EUL and pre-qualification of vaccines under which a company has to complete phase 3 trials and submit the whole data to the regulatory department of WHO which is examined by an expert advisory group," Swaminathan said.

Covid runs rampant in China as govt seems absent

Covid runs rampant in China as govt seems absent

Rediff.com26 Dec 2022

One Chinese source informed ANI that 10 million new infections are probably occurring daily in China.

Speedy distribution of vaccine major global challenge: WHO experts

Speedy distribution of vaccine major global challenge: WHO experts

Rediff.com5 Jan 2021

As India launches the world's most ambitious and biggest vaccination drive against COVID-19, the country will encounter the formidable challenge of rapidly scaling up distribution of the vaccines to secure immunity for its entire population, two prominent Indian scientists at World Health Organisation have said.

COVID-19 vaccine development at early stage in India: Experts

COVID-19 vaccine development at early stage in India: Experts

Rediff.com23 May 2020

The Indian government and private firms have stepped up efforts to develop a vaccine to halt the spread of COVID-19 which has claimed over 3,700 lives with more than 1,25,000 cases in the country.

PIO entrepreneur to bring smart glasses to India

PIO entrepreneur to bring smart glasses to India

Rediff.com4 Mar 2019

OXSIGHT, founded in 2016 to create wearable technology devices based on how the brain manages visual information, began conducting trials in India two years ago in partnership with leading eye hospitals and clinics.

Never dreamed my research would take the direction it has: Nobel Medicine Prize winner Allison

Never dreamed my research would take the direction it has: Nobel Medicine Prize winner Allison

Rediff.com2 Oct 2018

He is the first MD Anderson scientist to receive the world's most preeminent award for outstanding discoveries in the fields of life sciences and medicine.

COVID-19 vaccine: 'You can't give false hope'

COVID-19 vaccine: 'You can't give false hope'

Rediff.com14 Jul 2020

'We are going ahead with the trials assuming what we have is the vaccine.' 'There is also a chance that what you have is not the vaccine. Then, you have to go back to the drawing board again.' 'So far, there has been no success in developing a good vaccine against coronaviruses.' 'That's why there are hundreds of trials going on at different stages in different parts of the world.'

Why Covid Cases Are Rising

Why Covid Cases Are Rising

Rediff.com8 Jun 2022

'Since many people are vaccinated, this virus is now concentrating on the throat and the nose and replicating fast and transmitting also very fast.' 'That's because the current vaccines will not be able to fight it when it is in the throat, nose or the mouth.'

DRDO's 1st batch of anti-Covid drug 2DG launched

DRDO's 1st batch of anti-Covid drug 2DG launched

Rediff.com17 May 2021

The drug comes in powder form in a sachet, which is taken orally by dissolving it in water. It accumulates in the virus-infected cells and prevents virus growth by stopping viral synthesis and energy production.

Broke no rule, obtained licence for COVID-19 drug: Patanjali

Broke no rule, obtained licence for COVID-19 drug: Patanjali

Rediff.com25 Jun 2020

"The licence for the drug was obtained on the basis of the traditional knowledge and experience related to the medicinal virtues of Ashwagandha, Giloy and Tulsi," Patanjali spokesperson S K Tijarawala said.

Can avocados help delay diabetes?

Can avocados help delay diabetes?

Rediff.com27 Nov 2019

Avocation B (AvoB), a fat molecule found only in avocados counters incomplete oxidation in skeletal muscle and the pancreas to reduce insulin resistance.

PG Diploma at CREMA

PG Diploma at CREMA

Rediff.com16 Jan 2009

CREMA (Clinical Research Education and Management Academy) opens admissions for its one-year, part-time PG Diploma.

Govt developing multi-variant Covid-19 vaccine

Govt developing multi-variant Covid-19 vaccine

Rediff.com14 Sep 2021

Government institutions and pharma industry are examining if a 'cocktail' approach to making a multi-variant Covid-19 vaccine works against multiple strains of the ever-mutating virus, reports Sohini Das.

India's COVID-19 figures worrying: WHO chief scientist

India's COVID-19 figures worrying: WHO chief scientist

Rediff.com11 May 2021

Soumya Swaminathan called on governments to boost exercises on reporting actual numbers.

UK signs deal for 90 million COVID-19 vaccine doses

UK signs deal for 90 million COVID-19 vaccine doses

Rediff.com20 Jul 2020

To enable large-scale vaccine studies to take place across the UK, the aim is to get 500,000 people signed up by October, which is considered vital in the fight against coronavirus.

'I told them India was like a giant jumbo jet. It would take off slowly and be unstoppable'

'I told them India was like a giant jumbo jet. It would take off slowly and be unstoppable'

Rediff.com10 Jan 2023

This doctor couple put their faith in India. And in return India has put faith in them.

Rectal bleeding reported in 5 Covid patients; 1 dead

Rectal bleeding reported in 5 Covid patients; 1 dead

Rediff.com29 Jun 2021

Five COVID-19 patients have suffered cytomegalovirus-related rectal bleeding at a leading private facility in New Delhi during the second wave of the pandemic, hospital authorities said on Tuesday and claimed it was being reported for the 'first time' in immunocompetent persons.

The maverick who changed India's legal education

The maverick who changed India's legal education

Rediff.com10 Feb 2020

Whenever the history of India's National Law Schools is written, N R Madhava Menon's name will be deeply inscribed in it, says Mohammad Zeeshan Ahmad.

Israel develops key Covid antibody that 'attacks and neutralises' virus

Israel develops key Covid antibody that 'attacks and neutralises' virus

Rediff.com5 May 2020

The statement said that the antibody's development had been completed and that the institute was in the process of patenting the find 'and in the next stage, researchers will approach international companies to produce the antibody on a commercial scale'.

Daily Covid recoveries surpass new cases for 6 days

Daily Covid recoveries surpass new cases for 6 days

Rediff.com24 Sep 2020

A total 87,374 people have recuperated in a span of 24 hours in the country, while the number of new confirmed cases reported is 86,508, according to the data updated at 8 am.

Pfizer, BioNTech claim their Covid vaccine over 90% effective

Pfizer, BioNTech claim their Covid vaccine over 90% effective

Rediff.com10 Nov 2020

After discussion with the Food and Drug Administration (FDA), the companies recently elected to drop the 32-case interim analysis and conduct the first interim analysis at a minimum of 62 cases, the statement said.

Omicron variant stokes concern but vaccine still critical: Experts

Omicron variant stokes concern but vaccine still critical: Experts

Rediff.com29 Nov 2021

The Omicron variant carries 'concerning' mutations that may make it more transmissible and allow it to evade immunity, scientists said on Monday, stressing that the one certainty in the uncertainty of the many things unknown is this -- COVID is not a short-term crisis and vaccines are still a critical tool.

India sees record COVID-19 recoveries in single day

India sees record COVID-19 recoveries in single day

Rediff.com23 Jul 2020

As many as 29,557 COVID-19 patients have recuperated in the past 24 hours.

What is dry eye syndrome? Do you have it?

What is dry eye syndrome? Do you have it?

Rediff.com17 Nov 2018

The chronic dry eye is a common disease in which natural tears fail to adequately lubricate the eyes, thus drastically affecting its functioning.

Scientists sceptical about Russia's COVID-19 vaccine

Scientists sceptical about Russia's COVID-19 vaccine

Rediff.com12 Aug 2020

Scientists around the world, including in India, suggest it hasn't been tested properly given the time constraint and there may not be enough evidence to prove its efficacy.

At 7k, IIT grads design device to detect heart health

At 7k, IIT grads design device to detect heart health

Rediff.com24 Sep 2019

The device is powered by AI engine that conducts risk analysis on an individual's health data to note the slightest of deviations from their healthy baselines and detect any early signs of health deterioration.

3 generic HIV/AIDS drugs: Ranbaxy-Gilead pact

3 generic HIV/AIDS drugs: Ranbaxy-Gilead pact

Rediff.com12 Jul 2011

The company has entered into an 'in-licencing agreement' with Gilead Sciences Inc to produce and sell, under licence, three new HIV/AIDS drugs which are currently in late stages of clinical development, Ranbaxy Laboratories said.

Indian scientists develop low-cost COVID-19 test, Feluda

Indian scientists develop low-cost COVID-19 test, Feluda

Rediff.com22 Apr 2020

Named after 'Feluda', the detective character in legendary filmmaker Satyajit Ray's stories, the test has been developed by Debojyoti Chakraborty and Souvik Maiti as a simpler way of detecting SARS-coV2 presence in clinical samples, IGIB Director Anurag Agarwal said.

Record 73,642 COVID-19 patients recover in 24 hrs

Record 73,642 COVID-19 patients recover in 24 hrs

Rediff.com6 Sep 2020

"The spike in the daily recovered COVID-19 patients continues in the country. For the second successive day, India has clocked a record recovery of more than 70,000 patients in a single day," the government said.

Why the Very Young are Dying

Why the Very Young are Dying

Rediff.com2 Jun 2021

'We can't rule out the fact that the virus might have changed in such a way that it's actually causing more harm to young people.'

'No one is saying the vaccine is unsafe'

'No one is saying the vaccine is unsafe'

Rediff.com8 Jan 2021

'Nobody is attacking the company or the vaccine.' 'The concerns are about the process and the lack of transparency.'

Govt exploring possibility to produce Covaxin abroad

Govt exploring possibility to produce Covaxin abroad

Rediff.com21 May 2021

To address the shortage of COVID-19 jabs in the country, the government is exploring the possibility of boosting production of vaccines, including identifying manufacturing sites for indigenously developed Covaxin outside India, sources said.

30 groups in India trying to develop COVID-19 vaccine: PSA

30 groups in India trying to develop COVID-19 vaccine: PSA

Rediff.com28 May 2020

Without naming the entity, he said some players are at a pre-clinical stage and may reach the clinical stage by October. Responding to a question on absence of a vaccine currently and the prospects in the next few months as the lockdown eases, VijayRaghvan emphasised on aggressive rapid testing and tracking.

China exonerates itself in whitepaper on COVID-19

China exonerates itself in whitepaper on COVID-19

Rediff.com7 Jun 2020

A whitepaper released by the Chinese government gave a lengthy explanation to refute the allegations of cover up and delay by Beijing on reporting the COVID-19 outbreak last year in Wuhan. United States President Donald Trump and leaders of several countries have accused China of not being transparent in reporting the deadly disease, leading to huge human casualties and economic crisis across the world.

Piramal makes progress on cancer drug research

Piramal makes progress on cancer drug research

Rediff.com28 Aug 2009

PLSL's lead molecule under development for cancer treatment has completed two Phase-I studies.

Newton, Darwin take note: Gagandeep Kang makes history

Newton, Darwin take note: Gagandeep Kang makes history

Rediff.com8 May 2019

Women are great team players and collaborators, 'but they don't put themselves forward,' Dr Gagandeep Kang, the first Indian woman scientist to be elected as a Fellow of the Royal Society, tells Veenu Sandhu.

'It is common for any virus to mutate'

'It is common for any virus to mutate'

Rediff.com22 Dec 2020

'There is no data to show this virus is more deadlier.'

India rolls out world's largest vaccination drive against COVID-19

India rolls out world's largest vaccination drive against COVID-19

Rediff.com17 Jan 2021

The first COVID-19 vaccine shots in India were given on Saturday to nearly two lakh frontline healthcare and sanitary workers as Prime Minister Narendra Modi rolled out the world's largest inoculation drive against the pandemic that has caused 1,52,093 deaths and upended millions of lives in the country.